Wikidata

(Q44908437)

English

A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.

scientific article

In more languages

Statements

title
A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15160440
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15160440%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44908437&oldid=1561793868"